Maes, K., Hose, D., & Seckinger, A. (2015). In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma. OncoTarget, 6(5), . https://doi.org/10.18632/oncotarget.3207
Chicago-Zitierstil (17. Ausg.)Maes, Ken, Dirk Hose, und Anja Seckinger. "In Vivo Treatment with Epigenetic Modulating Agents Induces Transcriptional Alterations Associated with Prognosis and Immunomodulation in Multiple Myeloma." OncoTarget 6, no. 5 (2015). https://doi.org/10.18632/oncotarget.3207.
MLA-Zitierstil (9. Ausg.)Maes, Ken, et al. "In Vivo Treatment with Epigenetic Modulating Agents Induces Transcriptional Alterations Associated with Prognosis and Immunomodulation in Multiple Myeloma." OncoTarget, vol. 6, no. 5, 2015, https://doi.org/10.18632/oncotarget.3207.